Skip to Content

Neurogenesis Inc NEUN

Morningstar Rating
$0.00 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

NEUN is trading at a 42% discount.
Price
$0.00
Fair Value
$6.80
Uncertainty
Extreme
1-Star Price
$6.65
5-Star Price
$6.58
Economic Moat
Sdmbf
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if NEUN is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
$0.00 / $0.01
Market Cap
$8,226.21
Volume/Avg
10,000 / 11,405

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Neurogenesis Inc formulates nutritional supplements to assist in recovery from abuse of Alcohol, Opiates, Cocaine and Valium and various addictive behaviors that are caused from or intensified by the shortage or depletion of certain neurochemicals in the brain.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Total Number of Employees

Valuation

Metric
NEUN
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
NEUN
Quick Ratio
Current Ratio
Interest Coverage
Quick Ratio
No chart available

Profitability

Metric
NEUN
Return on Assets (Normalized)
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
ZTS
Zoetis Inc Class AZbrz$87.4 Bil
MKKGY
Merck KGaA ADRKpngvd$74.3 Bil
HLN
Haleon PLC ADRFcvl$38.5 Bil
VTRS
Viatris IncCvtfk$15.1 Bil
RDY
Dr Reddy's Laboratories Ltd ADRHhrfd$12.4 Bil
CTLT
Catalent IncWlqzccz$10.3 Bil
CURLF
Curaleaf Holdings IncKsb$3.6 Bil
PRGO
Perrigo Co PLCFpq$3.6 Bil
PBH
Prestige Consumer Healthcare IncSrfsbn$3.5 Bil
GTBIF
Green Thumb Industries IncYlbsw$3.1 Bil

Sponsor Center